Related Experiment Video
Updated: Jul 4, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Negative trials in nephrology: what can we learn?
James E Novak1, Jula K Inrig, Uptal D Patel
1Division of Nephrology, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA. novak005@mc.duke.edu
Abstract:
Chronic kidney disease is assuming epidemic proportions, and an increasing number of clinical trials are testing treatments developed to improve morbidity and mortality. Surprisingly, however, a large proportion of these trials have had negative or neutral results. When trials unexpectedly demonstrate either no benefit or a detrimental impact of a treatment, especially when that treatment is already used in practice, critics commonly argue that the results were dictated by flawed trial design rather than the intrinsic properties of the treatment. In kidney disease therapeutics, trials commonly rely on observational data and test the hypothesis that these associations may be extrapolated to cause-and-effect. Other key issues in trial design that may affect outcomes include the impact of enrolling relatively healthier subjects, the complexity of recruiting participants with specific characteristics while maintaining generalizability, and the subtleties of event adjudication and quality of life assessments. In this article, general principles of trial design will be discussed and the potential lessons learned from recent trials in nephrology will be critically reviewed.
Insights
Clinical trials for chronic kidney disease treatments often yield neutral or negative results. Flaws in trial design, not the treatments themselves, may explain these outcomes in nephrology research.
Area of Science:
- Nephrology
- Clinical Trial Design
- Medical Research Methodology
Background:
- Chronic kidney disease (CKD) is a growing global health concern.
- Numerous clinical trials aim to improve CKD morbidity and mortality.
- Many CKD treatment trials report negative or neutral findings, questioning treatment efficacy.
Purpose of the Study:
- To critically review general principles of clinical trial design.
- To analyze potential design flaws impacting recent nephrology trials.
- To understand why CKD treatments may appear ineffective in trials.
Main Methods:
- Discussion of general principles in clinical trial design.
- Critical review of recent clinical trials in nephrology.
- Analysis of common issues in trial design, including data extrapolation, subject selection, and outcome assessment.
Main Results:
- A significant proportion of CKD trials show no benefit or detrimental effects.
- Trial design issues, such as reliance on observational data and subject selection, may confound results.
- Methodological challenges in event adjudication and quality of life assessments can impact trial outcomes.
Conclusions:
- Flawed clinical trial design may lead to incorrect conclusions about treatment efficacy in CKD.
- Careful consideration of trial methodology is crucial for accurate assessment of nephrology therapeutics.
- Re-evaluation of trial design principles is needed to improve the reliability of CKD research findings.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Nephrons
Diabetic Nephropathy
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
